Genpact Limited (G)
NYSE: G
· Real-Time Price · USD
42.20
0.41 (0.98%)
At close: Sep 26, 2025, 3:59 PM
42.22
0.04%
After-hours: Sep 26, 2025, 06:08 PM EDT
Genpact Revenue Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
|---|---|---|---|---|---|---|---|
| Consumer And Healthcare Revenue | 428.56M | 420.48M | 1.22B | 404.18M | 748.39M | 388.07M | 373.08M |
| Consumer And Healthcare Revenue Growth | +1.92% | -65.60% | +202.41% | -45.99% | +92.85% | +4.02% | n/a |
Revenue by Geography
| Period Ending | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 |
|---|---|---|---|---|---|---|---|---|
| Americas Revenue | 240.88M | 233.06M | 208.05M | 181.76M | 185.47M | 152.12M | 151.84M | 152.28M |
| Americas Revenue Growth | +3.35% | +12.02% | +14.46% | -2.00% | +21.93% | +0.19% | -0.29% | n/a |
| Asia Other Than India Revenue | 95.26M | 86.01M | 81.79M | 93.66M | 85.93M | 83.84M | 78.23M | 79.46M |
| Asia Other Than India Revenue Growth | +10.76% | +5.16% | -12.67% | +9.00% | +2.48% | +7.18% | -1.55% | n/a |
| Europe Revenue | 109.69M | 96.83M | 105.61M | 97.04M | 86.71M | 103.84M | 33.57M | 68.04M |
| Europe Revenue Growth | +13.28% | -8.31% | +8.83% | +11.92% | -16.50% | +209.34% | -50.66% | n/a |
| India Revenue | 494.91M | 472.9M | 486.35M | 436.74M | n/a | n/a | n/a | 389.13M |
| India Revenue Growth | +4.65% | -2.77% | +11.36% | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 266.39M | 241.08M | 249.16M | 243.31M | 239.64M | 235.03M | 237.42M | 229.73M | 229.43M | 216.49M | 236.56M | 231.44M | 233.1M | 237.3M | 244.86M | 215.96M | 204.17M | 200.73M | 207.86M | 198.34M | 186.31M | 197.34M | 210.05M | 194.54M | 194.2M | 188.69M | 177.94M | 165.39M | 173.55M | 168.46M | 186.49M | 169.53M | 165.41M | 158.38M | 168.35M | 154.67M | 163.01M | 157.98M | 163.27M | 142.49M | 146.98M | 146.4M |
| Selling, General, and Administrative Revenue Growth | +10.50% | -3.24% | +2.40% | +1.53% | +1.96% | -1.01% | +3.35% | +0.13% | +5.98% | -8.49% | +2.21% | -0.71% | -1.77% | -3.09% | +13.38% | +5.77% | +1.71% | -3.43% | +4.80% | +6.45% | -5.59% | -6.05% | +7.97% | +0.18% | +2.92% | +6.04% | +7.59% | -4.70% | +3.02% | -9.67% | +10.00% | +2.49% | +4.44% | -5.92% | +8.85% | -5.12% | +3.19% | -3.24% | +14.58% | -3.05% | +0.39% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |